0 202

Cited 0 times in

Identification of novel deletion regions on chromosome arms 2q and 6p in breast carcinomas by amplotype analysis

 Zhe Piao  ;  Kyong Sik Lee  ;  Hoguen Kim  ;  Manuel Perucho  ;  Sergei Malkhosyan 
 GENES CHROMOSOMES & CANCER, Vol.30(2) : 113-122, 2001 
Journal Title
Issue Date
Breast Neoplasms/genetics* ; Breast Neoplasms/pathology ; Chromosome Deletion* ; Chromosome Mapping ; Chromosomes, Human, Pair 2/genetics* ; Chromosomes, Human, Pair 6/genetics* ; DNA Fingerprinting/methods ; Female ; Gene Dosage ; Humans ; Karyotyping ; Loss of Heterozygosity ; Microsatellite Repeats
DNA fingerprinting by arbitrarily primed PCR (AP-PCR) was employed to identify molecular genetic alterations in 37 primary breast carcinomas. AP-PCR is a PCR-based technique that uses only one primer of arbitrary sequence that generates a molecular karyotype (amplotype) of tumors. The breast cancer amplotype generated with two arbitrary primers (MCG1 and Blue) showed a relatively high frequency (more than 20% of the tumors) of gains at chromosomes 1, 4, and 8, and of losses at chromosomes 2, 4, 6, 9, 10, 11, 13, and the X chromosome. We further analyzed the regions most commonly gained at chromosome 8 (47%) and lost at chromosomes 2 (38%) and 6 (49%) by determining the subchromosomal localization of the fingerprint bands from these chromosomes. The region of gain at chromosome 8 was mapped at 8q24.1, close to MYC. Band MCG1-A1 was assigned to chromosome band 2q22, and band Blue-J was assigned to 6p21. Common losses of these chromosomal regions have not been described for breast cancer. To map these deletion regions more precisely, we performed loss of heterozygosity (LOH) analysis by microallelotyping on 20 of the 37 cancers previously analyzed by AP-PCR and another additional 52 breast carcinomas. The results suggest that the regions at 2q21–24 and 6p21–23 may harbor novel tumor suppressor genes for breast cancer. LOH at 2q21–24 (D2S2304) was more frequent in high-grade tumors (59%) than in low-grade tumors (29%) (P = 0.03). This suggests that this genetic alteration may be associated with tumor progression and shows the power of the amplotype approach in detecting novel genetic alterations that are useful as clinical parameters of breast cancer
Full Text
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Pathology (병리학교실) > 1. Journal Papers
Yonsei Authors
Kim, Hogeun(김호근)
사서에게 알리기


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.